USP unveils Trust Accelerated Program to help speed development of quality COVID-19 treatments and vaccines
ROCKVILLE, Md. — To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide. In response to overwhelming demand, with 2,000 downloads of select COVID-related USP standards made available in March, Trust Accelerated offers expanded access to free
